155 related articles for article (PubMed ID: 30809785)
1. Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?
Lillemoe HA; Marcus RK; Kim BJ; Narula N; Davis CH; Aloia TA
J Gastrointest Surg; 2019 Dec; 23(12):2362-2371. PubMed ID: 30809785
[TBL] [Abstract][Full Text] [Related]
2. Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.
Lillemoe HA; Marcus RK; Kim BJ; Narula N; Davis CH; Shi Q; Wang XS; Aloia TA
Ann Surg Oncol; 2019 Dec; 26(13):4548-4555. PubMed ID: 31414293
[TBL] [Abstract][Full Text] [Related]
3. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.
Aloia TA; Zimmitti G; Conrad C; Gottumukalla V; Kopetz S; Vauthey JN
J Surg Oncol; 2014 Aug; 110(2):107-14. PubMed ID: 24846705
[TBL] [Abstract][Full Text] [Related]
4. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
5. Faster Return to Intended Oncologic Treatment (RIOT) After Trisectionectomy Does Not Translate to Better Outcomes.
Baimas-George M; Watson M; Pickens RC; Sulzer J; Murphy KJ; Ocuin L; Baker E; Martinie J; Iannitti D; Vrochides D
Am Surg; 2021 Feb; 87(2):309-315. PubMed ID: 32936007
[TBL] [Abstract][Full Text] [Related]
6. Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients.
Ramos MFKP; de Castria TB; Pereira MA; Dias AR; Antonacio FF; Zilberstein B; Hoff PMG; Ribeiro U; Cecconello I
J Gastrointest Surg; 2020 Jan; 24(1):19-27. PubMed ID: 31745892
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Hepatic and Visceral Resection: Preoperative Risk Stratification and Implications on Return to Intended Oncologic Therapy.
Sinnamon AJ; Luo E; Xu A; Zhu S; Denbo JW; Fleming JB; Anaya DA
Ann Surg Oncol; 2023 Mar; 30(3):1772-1783. PubMed ID: 36418800
[TBL] [Abstract][Full Text] [Related]
8. Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.
Kiong KL; Moreno A; Vu CN; Zheng G; Rosenthal DI; Weber RS; Lewis CM
Oral Oncol; 2022 Jul; 130():105906. PubMed ID: 35594776
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery.
Day RW; Cleeland CS; Wang XS; Fielder S; Calhoun J; Conrad C; Vauthey JN; Gottumukkala V; Aloia TA
J Am Coll Surg; 2015 Dec; 221(6):1023-30.e1-2. PubMed ID: 26611799
[TBL] [Abstract][Full Text] [Related]
10. Influence of obesity on in-hospital and postoperative outcomes of hepatic resection for malignancy: a 10-year retrospective analysis from the US National Inpatient Sample.
He J; Liu H; Deng L; Wei X; Chen T; Xia S; Liu Y
BMJ Open; 2019 Aug; 9(8):e029823. PubMed ID: 31462479
[TBL] [Abstract][Full Text] [Related]
11. Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
Andreou A; Struecker B; Raschzok N; Krenzien F; Haber P; Wabitsch S; Waldbaur C; Touet EM; Eichelberg AC; Atanasov G; Biebl M; Bahra M; Öllinger R; Schmelzle M; Pratschke J
Surg Oncol; 2018 Dec; 27(4):751-758. PubMed ID: 30449503
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma for various resection extent.
Chen J; Li H; Liu F; Li B; Wei Y
Medicine (Baltimore); 2017 Mar; 96(12):e6460. PubMed ID: 28328863
[TBL] [Abstract][Full Text] [Related]
13. Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study.
Naffouje SA; Kamarajah SK; Denbo JW; Salti GI; Dahdaleh FS
Ann Surg Oncol; 2022 Nov; 29(12):7793-7803. PubMed ID: 35960450
[TBL] [Abstract][Full Text] [Related]
14. Enhanced recovery in the resection of colorectal liver metastases.
Dunne DF; Yip VS; Jones RP; McChesney EA; Lythgoe DT; Psarelli EE; Jones L; Lacasia-Purroy C; Malik HZ; Poston GJ; Fenwick SW
J Surg Oncol; 2014 Aug; 110(2):197-202. PubMed ID: 24715651
[TBL] [Abstract][Full Text] [Related]
15. Early Return to Intended Oncologic Therapy after implementation of an Enhanced Recovery After Surgery pathway for gastric cancer surgery.
Garcia-Nebreda M; Zorrilla-Vaca A; Ripollés-Melchor J; Abad-Motos A; Alvaro Cifuentes E; Abad-Gurumeta A; Mena GE; Grant MC; Paseiro-Crespo G
Langenbecks Arch Surg; 2022 Sep; 407(6):2293-2300. PubMed ID: 35441358
[TBL] [Abstract][Full Text] [Related]
16. Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.
Tufo A; Dunne DFJ; Manu N; Joshi H; Lacasia C; Jones L; Malik HZ; Poston GJ; Fenwick SW
Eur J Surg Oncol; 2018 Jul; 44(7):1040-1047. PubMed ID: 29456045
[TBL] [Abstract][Full Text] [Related]
17. Robotic Major Hepatectomy: Influence of Age on Clinical Outcomes.
Sucandy I; Luberice K; Rivera-Espineira G; Krill E; Castro M; Bourdeau T; Ross S; Rosemurgy A
Am Surg; 2021 Jan; 87(1):114-119. PubMed ID: 32841058
[TBL] [Abstract][Full Text] [Related]
18. Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy.
Mathur AK; Ghaferi AA; Sell K; Sonnenday CJ; Englesbe MJ; Welling TH
J Gastrointest Surg; 2010 May; 14(5):849-57. PubMed ID: 20140536
[TBL] [Abstract][Full Text] [Related]
19. National Trends and Perioperative Outcomes of Robotic-assisted Hepatectomy in the USA: A Propensity-score Matched Analysis from the National Cancer Database.
Kamel MK; Tuma F; Keane CA; Blebea J
World J Surg; 2022 Jan; 46(1):189-196. PubMed ID: 34528104
[TBL] [Abstract][Full Text] [Related]
20. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.
Xiong JJ; Nunes QM; Huang W; Pathak S; Wei AL; Tan CL; Liu XB
World J Gastroenterol; 2013 Dec; 19(46):8731-9. PubMed ID: 24379593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
